PhotonPharma, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer (NCT06366490) | PhotonPharma, Inc. | 2026-02-12 |
Track PhotonPharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.